Sharon Ramey

Research Professor and Distinguished Research Scholar

Virginia Tech
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (2)

In this summation of the Abecedarian Project (1971-2025) we present our lifespan biosocial model of learning that emphasizes the development of Functional Intelligence. Functional Intelligence is what an individual, at each age period and in dominant environmental contexts, accomplishes in socially-valued domains of living through thinking and behavior. The Abecedarian Project is a randomized controlled trial (RCT) to prevent intellectual and social subnormality in children born into extremely high-risk social and economic circumstances. A full-day, year-round early education program for the first 5 years of life was the core of the early intervention. The control group received nutritional supplements, pediatric care, and family social work services, as did the intervention group, but not the early education intervention. Teacher-child transactions were construed as Developmental Priming Mechanisms. The model specifies 5 cumulative learning and cognitive processes. Central features include recognizing culturally powerful ecological contexts and relevant domains of knowledge within those contexts. The initial goal of the early educational program was to promote cognitive and language development and ensure high levels of school preparedness at kindergarten entry. Evidence is provided that supports the conclusion that the Abecedarian Early Education Program positively affected assessed intelligence and developmental competence from 18 months through school entry, followed by consistently higher achievement in academic areas of reading and mathematics at all tested ages through early adulthood. Rates of retention in grade and placement in special education also were markedly reduced. Longer-term outcomes in adulthood, from their early 20s through middle age in their 30s and 40s, demonstrated significant benefits related to health, especially cardiovascular biomarkers, and increased functional intelligence (i.e., effective real-world thinking and acting) including attaining more years of education and degrees post-high school, having higher rates of full-time employment, greater self-sufficiency, closer positive relationships with both their mothers and fathers, displaying longer future planning horizons, adopting better decision-making strategies, and having evidence of structural brain differences in both overall cortex size and in 4 of 5 hypothesized brain regions theoretically linked to the early education intervention and active learning and language processes. We conclude that future early education interventions might usefully focus on understanding changes in developmental trajectories during and after the intervention and the forces that regulate both individual stability and change. Characterizations of impact might also seek to capture more fully the multiple experiential contexts where study participants spend time, both during and after the planned educational intervention, and identifying the types of functional intelligence skills that optimize success in those contexts. A joint focus on changes in developmental trajectories and the specification of important and facilitative (versus thwarting) contexts is consistent with a dynamic biosocial systems and its probabilistic, multi-domain perspective on human development. This conceptual framework puts the focus of scientific efforts relating to learning, health, educational achievement, personal life satisfaction, and becoming an engaged and contributory adult citizen on further specifying the effective (and sometimes alternative or compensatory) components to support developmental advances within and across the various functional domains as well as periods in the lifespan.

Year:

2025

Introduction Over 11,000 infants are diagnosed with cerebral palsy (CP) each year, with lifetime medical costs exceeding $1.4 million per person. Elevated muscle tone in CP, including dystonia and spasticity, significantly impairs function and quality of life. Intrathecal baclofen (ITB) is commonly used to manage dystonic CP, though evidence supporting its effectiveness is weak due to patient variability and study limitations. Spasticity may obscure dystonia symptoms, and factors like brain injury patterns and pain triggers are often overlooked in research. Despite uncertain effects on dystonia, ITB has shown benefits in pain relief, comfort, and caregiving ease. This proposal aims to evaluate ITB’s overall impact on children with dystonic CP, identify responders, and develop a comprehensive outcome measure using a prospective cohort study. Methods and Analysis We will conduct a prospective, observational study of 65 children with dystonia (Barry Albright Dystonia Scale (BADS) greater than 15) and CP who receive ITB. Changes in dystonia, spasticity, gross and fine motor function, and multiple patient-reported outcomes related to quality-of-life, depression, anxiety, pain and more. The primary analysis will use repeated measures models to estimate short and long-term changes from baseline in BADS scores at 3, 6 and 12-months. Secondary analysis will apply the same strategies to the other outcome measures. We will also conduct subgroup analysis and develop a multidimensional or composite measure. Ethics and dissemination Primary ethic approval was provided by the Baylor College of Medicine Institutional Review Board (H-54449). Results of the study will be disseminated via peer-reviewed presentations at scientific conferences and open access publication. Trial Registration Number NCT06606574 ( clinicaltrials.gov ) STRENGTHS AND LIMITATIONS Unlike previous studies on ITB in dystonia and CP, a strength of this study is that it will directly measure effects of ITB beyond just dystonia, while also considering the child’s co- existing spasticity if present, known triggers of dystonia, including pain, and CNS injury patterns contributing to dystonia. We consider multiple endpoints or the “total child” within the ICF Framework and whether concurrent therapeutic interventions appear to influence outcomes. A limitation of the study is the lack of randomization to placebo or blinding.

Year:

2025

Collaborators (4)

Mark Conaway

Professor

University of Virginia

UNITED STATES
View details

Sruthi Thomas

Associate Professor

Baylor College of Medicine

UNITED STATES
View details

Jeffrey S. Raskin

Neurosurgeon

Ann and Robert H Lurie Children's Hospital of Chicago

UNITED STATES
View details

Darcy Fehlings

-

CANADA
View details